SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950117-98-001124
Filing Date
1998-05-22
Accepted
1998-05-22 00:00:00
Documents
3
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 ELI LILLY & CO. 13D/A #1 SC 13D/A 9319
2 EXHIBIT A EX-99 4771
3 EXHIBIT B EX-99 3524
  Complete submission text file 0000950117-98-001124.txt   19812
Mailing Address LILLY CORPORATE CENTER DROP CODE 1112 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1112 INDIANAPOLIS IN 46285 3172762000
LILLY ELI & CO (Filed by) CIK: 0000059478 (see all company filings)

IRS No.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9393 TOWNE CENTRE DRIVE SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DR STE 100 SAN DIEGO CA 92121 6195353900
LIGAND PHARMACEUTICALS INC (Subject) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-43329 | Film No.: 98630678
SIC: 2834 Pharmaceutical Preparations